Screen LibraryControversial statistical issues in clinical trials
Saved in:
| Main Authors: | |
|---|---|
| Published: |
CRC Press,
|
| Publisher Address: | Boca Raton |
| Publication Dates: | c2011. |
| Literature type: | Book |
| Language: | English |
| Series: |
Chapman & Hall/CRC biostatistics series |
| Subjects: | |
| Carrier Form: | xix, 591 p.: ill. ; 25 cm. |
| ISBN: |
9781439849613 (hardback : acid-free paper) 1439849617 (hardback : acid-free paper) |
| Index Number: | R969 |
| CLC: | R969.4 |
| Call Number: | R969.4/C552 |
| Contents: |
Includes bibliographical references (p. 553-575) and index. "Preface In pharmaceutical/clinical development of a test drug or treatment, relevant clinical data are usually collected from subjects with the diseases under study in order to evaluate safety and efficacy of the test drug or treatment under investigation. To provide accurate and reliable assessment, well-controlled clinical trials under valid study design are necessarily conducted. Clinical trial process is a lengthy and costly process, which is necessary to ensure a fair and reliable assessment of the test treatment under investigation."-- |